Adiuvo InvestmentsS.A.

Other financial service activities, except insurance and pension funding not elsewhere

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-08-24
Activity description

Adiuvo Investments acquires and invests in life-science projects and biomedical technologies. The company focuses on commercializing products that support prevention, health monitoring, and patient participation in treatment, including on international markets. It also works on intellectual property protection, technology validation, and obtaining certifications needed to place products on the market.

Registered address
ul. Szara 10, 00-420 Warszawa, Poland
Website
adiuvoinvestments.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-50780-54832-DSGIC-13

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 0.61
-0.02 (-2.57%)
0.590.600.610.6110:0012:0014:0016:00
Open
PLN 0.59
High
PLN 0.61
Low
PLN 0.59
Volume
27.99K
Avg. vol.
70.65K
Market cap
PLN 98.63M
P/E ratio
—
EPS
-PLN 0.27
Shares outstanding
162.75M
52-week
PLN 0.58 – 0.74
Dividend yield
—
Dividend
—
Ex dividend date
—
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q1 2026USD 12.43kUSD -246.62kUSD -376.82k
Q4 2025USD -27.12kUSD 10.30kUSD -79.36k
Q3 2025USD 85.89kUSD -220.74kUSD -298.34k
Q2 2025USD 37.92kUSD -225.26kUSD -176.80k

Results for Q3 2026:Nov 30, 2026

Bank accounts

Registered as a VAT taxpayer on 2012-08-27. Active

  • mBank
    28 1140 1010 0000 5412 8400 1005
  • mBank
    44 1140 1010 0000 5412 8400 1008
  • mBank
    98 1140 1010 0000 5412 8400 1006

Debt

3 closed proceedings recorded in KRZ history. Closed proceedings in history

Registration dateProceeding typeStatus
Dec 2, 2024
Accelerated arrangement proceedings
Closed
Oct 21, 2024
Petition to open accelerated arrangement proceedings
Closed
Sep 16, 2024
Petition to open accelerated arrangement proceedings
Closed

MSiG notices

Publication dateEvent
Feb 19, 2019Merger registered
Mar 17, 2015Commercial Companies Code notice

Public aid

7 public aid cases recorded, with a total value of $19,325.

Grant datePurposeGross amountGranting body
Nov 25, 2022
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$206Prezes Zakładu Ubezpieczeń Społecznych
Nov 25, 2022
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$201Prezes Zakładu Ubezpieczeń Społecznych
Oct 10, 2022
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$206Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Authorized Representatives

Anna Aranowska Bablok — Management Board Member
Marek Jan Orłowski — President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will and sign on behalf of the company, whereas in the case of a multi-member management board, 2 members of the management board acting jointly or 1 member of the management board acting jointly with a commercial proxy are authorised to do so.

Supervisory board

Krzysztof Adam Laskowski — Supervisory Board Member
Bogusław Andrzej Ulijasz — Supervisory Board Member
Wojciech Marek Bablok — Supervisory Board Member
Emil Tomaszewski — Supervisory Board Member
Giuseppe Schembri — Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Adiuvo Investments.

Subsidiaries

NameShare valueStake
27,012.43 USD100%
Algaelabssp. z o.o.
17,450.03 USD65.8512%

Competitors

Change history

DateEvent
2025-02-20Name change (Adiuvo Investments → Adiuvo Investments Spółka Akcyjna W Restrukturyzacji)
2024-03-26Address change (Ul. Gen. Józefa Zajączka 11/14, 01-510, Warszawa → Ul. Szara 10, 00-420, Warszawa)
2020-02-17Address change (Ul. Słomińskiego 15/509, 00-195, Warszawa → Ul. Gen. Józefa Zajączka 11/14, 01-510, Warszawa)
2019-05-10Share capital change (1,178,434.60 PLN → 1,317,434.60 PLN)
2018-11-08Share capital change (1,016,434.60 PLN → 1,178,434.60 PLN)

FAQ

Last updated: 2026-03-24